Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 5Neoplasm Metastasis 2Lung Neoplasms 2Brain Neoplasms 2Wilms Tumor 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Thyroid Cancer, Papillary 1Prostatic Neoplasms 1Precancerous Conditions 1Pleural Effusion, Malignant 1Osteoporosis 1Neoplasms 1Lymphatic Metastasis 1Kidney Neoplasms 1Gliosarcoma 1Glioblastoma 1Cervical Neoplasia 1Carcinoma, Non-Small-Cell Lung 1Barrett Esophagus 1Adenocarcinoma Of Esophagus 1

Interventions

aldesleukin 43Sunitinib 42Cyclophosphamide 30Nivolumab 29pembrolizumab 27Everolimus 27Interferon-alpha 25Bevacizumab 23Sorafenib 22Interleukin-2 20fludarabine phosphate 19Radiotherapy 18Ipilimumab 18Filgrastim 18Axitinib 18Gene Expression Profiling 16Peripheral Blood Stem Cell Transplantation 15Gemcitabine 15cabozantinib 14Radiosurgery 13fludarabine 11Doxorubicin 11Carboplatin 11Blood Specimen Collection 11temsirolimus 10atezolizumab 9Immunohistochemistry 9Etoposide 9Chemotherapy, Adjuvant 9sargramostim 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Kidney Neoplasms × Spectrum Analysis × Clear all
NCT01542333 2016-05-18

Studying Biomarkers in Samples From Younger Patients With Wilms Tumor

Children's Oncology Group

Completed
20 enrolled
Genitourinary

Kidney Neoplasms, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡